At the heart of this innovation is the combination of mid-infrared light, known for its ability to probe molecular vibrations, with photoacoustic microscopy, a technique that converts absorbed optical energy into acoustic signals. The integration of dichroism sensitivity adds a new dimension—it allows the detection of anisotropic molecular orientations within tissue samples. This is particularly significant in the context of engineered heart tissues, where the alignment and structural organization of cellular and extracellular matrix components critically dictate tissue function.

Histological analysis has long been essential for evaluating tissue architecture during the development and maturation of bioengineered cardiac constructs. Traditional staining and imaging methods, while valuable, often require invasive preparation steps that can alter tissue integrity and are limited in their ability to offer molecular-level insights. The newly developed mid-infrared dichroism-sensitive photoacoustic microscopy technique addresses these limitations by providing a label-free methodology that preserves native tissue state, enabling high-resolution, chemically specific imaging.

The principle of operation hinges on the unique absorption properties of molecular bonds in the mid-infrared spectral region. As mid-infrared light excites vibrational modes of molecules such as proteins and lipids, the subsequent non-radiative relaxation generates localized thermoelastic expansion. This produces acoustic waves detectable by ultrasound transducers, forming the basis of photoacoustic microscopy. By exploiting dichroism—the dependency of absorption on the polarization direction of incident light—the system reveals anisotropic molecular arrangements, unveiling detailed structural alignment within the tissue.

Engineered heart tissues require meticulous structural organization to emulate native myocardial function, which is primarily governed by the orientation of contractile proteins and extracellular matrix fibers. The capacity of this technology to detect and image such molecular anisotropy noninvasively not only accelerates tissue characterization but also opens avenues for real-time monitoring of tissue maturation during cultivation.

The researchers demonstrated this method on various engineered cardiac constructs, highlighting its capability to visualize intricate histological features such as fiber alignment, cell distribution, and extracellular matrix composition. Compared to conventional imaging modalities, the label-free mid-infrared photoacoustic approach offers superior chemical specificity without compromising spatial resolution—facilitating direct correlation between structural features and functional properties of the tissue.

Moreover, the utilization of mid-infrared wavelengths addresses a critical challenge in biomedical imaging: the trade-off between penetration depth and molecular specificity. While shorter wavelengths enable higher resolution, they lack chemical contrast, and longer wavelengths often suffer from limited tissue penetration. The photoacoustic effect circumvents these issues by detecting ultrasound signals rather than light directly, enabling the deep interrogation of thick tissue samples without sacrificing molecular detail.

Another advantage of this platform is its compatibility with live tissue environments, potentially allowing longitudinal studies of tissue development and disease progression. This dynamic monitoring capability is transformative for regenerative medicine, where the functionality of bioengineered tissues must be validated prior to transplantation or therapeutic use.

The detailed spectroscopic information afforded by the system enhances the diagnostic potential beyond structural imaging. By discerning specific molecular fingerprints, it could help identify pathological changes or deviations in tissue composition indicative of disease states or insufficient tissue engineering protocols. This diagnostic precision paves the way for personalized medicine applications, where tailored treatments depend on an accurate understanding of tissue microenvironments.

Integration of this photoacoustic microscopy paradigm with existing cardiac tissue engineering workflows promises to streamline the validation process of tissue constructs. Researchers and clinicians can benefit from expedited, non-destructive assessments that preserve valuable samples for further analysis or therapeutic application. This approach fosters a more efficient pipeline from laboratory development to clinical translation.

The mid-infrared dichroism-sensitive photoacoustic microscopy embodies a convergence of optical physics, acoustics, and bioengineering, showcasing how interdisciplinary strategies can surmount longstanding challenges in biomedical imaging. As the technology matures, scaling and automation may facilitate its adoption in routine tissue analysis laboratories and regenerative medicine clinics worldwide.

Future directions may include expanding the approach to other tissue types where molecular orientation and composition critically influence function, such as neural, musculoskeletal, and connective tissues. Additionally, coupling with machine learning algorithms for image analysis could accelerate data interpretation, enabling rapid phenotyping and quality control of engineered tissues at scale.

The implications of this innovation extend beyond engineered heart tissues alone. The foundational principles could spur a new generation of label-free imaging techniques that capture the complexities of tissue biology with minimal preparation and maximal informational content. This shift toward non-invasive, chemically informative imaging heralds a new era in histopathology and tissue engineering research.

By enabling detailed visualization of histostructural features, this mid-infrared photoacoustic microscopy method holds the promise to deepen our understanding of cardiac biology and enhance the development of therapies for heart disease. As cardiovascular conditions remain a leading cause of morbidity and mortality globally, tools that refine engineered tissue characterization are vital for advancing regenerative solutions.

In summary, the advent of label-free mid-infrared dichroism-sensitive photoacoustic microscopy marks a significant leap forward in the field of biomedical imaging and tissue engineering. Its ability to combine chemical specificity, structural resolution, and deep tissue penetration without the need for exogenous labels positions it as an indispensable tool for the future of cardiac tissue research and therapy development.

As this technique gains wider acceptance and technical refinements, it is poised to become a cornerstone method for the histostructural analysis of engineered tissues, ultimately contributing to improved clinical outcomes for patients suffering from heart disease and possibly a broad spectrum of other disorders where tissue architecture is a critical parameter.

Subject of Research: Histostructural analysis of engineered heart tissues using label-free mid-infrared dichroism-sensitive photoacoustic microscopy.

Article Title: Label-free mid-infrared dichroism-sensitive photoacoustic microscopy for histostructural analysis of engineered heart tissues.

Article References:
Park, E., Hwang, D.G., Choi, H. et al. Label-free mid-infrared dichroism-sensitive photoacoustic microscopy for histostructural analysis of engineered heart tissues. Light Sci Appl 15, 49 (2026). https://doi.org/10.1038/s41377-025-02117-0

Image Credits: AI Generated

DOI: 10.1038/s41377-025-02117-0

At the heart of this advancement lies the strategic molecular modification of the xanthene scaffold by introducing diphenylamine groups. This substitution significantly increases the molecular flexibility by adding freely rotatable single bonds and induces pronounced molecular asymmetry. These structural changes are instrumental in strengthening the aggregation-induced emission—a phenomenon where molecular assemblies emit light more efficiently than individual molecules—thus overcoming the limitations of traditional dyes prone to aggregation-caused quenching. The enhanced AIE character not only improves fluorescence brightness under physiological conditions but also facilitates the dual therapeutic and diagnostic (theranostic) potential essential for precision oncology.

One of the pivotal findings in this work is the tunability of the optical and therapeutic properties through variation in the number of cyano groups attached to the dye molecules. Cyano groups, known for their strong electron-withdrawing capacity, modulate the electronic distribution within the dye framework. By adjusting these substituents, the researchers finely tuned the excitation wavelengths into the near-infrared window, a spectral region highly desirable for biomedical applications due to minimal tissue absorption and deeper penetration depth. This molecular tailoring also affects the efficiency of reactive oxygen species (ROS) generation required for PDT and the photothermal conversion efficiencies critical for PTT.

Among the synthesized dyes, Hcy-ON emerged as a standout candidate with unparalleled photodynamic and photothermal performance under 760 nm laser irradiation. Upon exposure to this near-infrared light, Hcy-ON efficiently generates reactive oxygen species, which induce cytotoxic effects targeting cancer cells. Simultaneously, the dye exhibits excellent heat-generating capabilities, enabling it to ablate tumors through localized hyperthermia. This dual-functionality is especially valuable in the context of combined or multimodal cancer therapies, where synergistic mechanisms can enhance treatment outcomes while minimizing side effects.

The mechanistic origins of Hcy-ON’s extraordinary performance were elucidated through in-depth molecular theoretical calculations. Notably, the dye demonstrated a significant spin–orbit coupling matrix element (SOCME), a quantum mechanical parameter pivotal in facilitating effective intersystem crossing from the excited singlet state (S1) to the triplet state (T1). This transition is critical for ROS production as it populates the triplet state necessary for energy transfer to molecular oxygen, forming cytotoxic singlet oxygen species. With a minimal energy gap of only 0.678 eV between S1 and T1, Hcy-ON efficiently navigates these electronic states, enhancing its PDT capability.

Furthermore, the research team conducted comprehensive analyses of photothermal properties by investigating multiple physicochemical parameters, including the singlet–triplet energy gap, electron transition dynamics, root-mean-square displacement (RMSD), and the Huang–Rhys factor. These factors collectively describe the vibrational coupling and structural relaxation processes following photoexcitation, which are closely tied to the ability of the dye to convert absorbed photon energy into localized heat. The relatively large RMSD and Huang–Rhys factors observed for Hcy-ON correlate well with its impressive photothermal conversion efficiency, marking it as a robust photothermal agent.

Beyond therapeutic implications, the dyes hold promise as contrast agents for photoacoustic imaging. PAI combines the optical excitation with ultrasonic detection, offering high-resolution visualization of deep tissues. The near-infrared absorption and strong photothermal effects of these dyes enhance photoacoustic signal generation, potentially enabling more precise tumor localization and real-time monitoring of therapeutic progress. The multifunctional nature of these dyes, facilitated by rational molecular design, heralds new paradigms in non-invasive cancer diagnostics and therapy.

The electron-acceptor engineering strategy employed here exemplifies the power of precision molecular design in tailoring excited-state dynamics to elicit desired photophysical outcomes. By manipulating donor–acceptor interactions within the molecular framework, the researchers have effectively controlled radiative and non-radiative decay pathways. This control translates into optimized emission properties and maximized photothermal and photodynamic effects, demonstrating the sophistication achievable in next-generation theranostic agents.

This study also highlights the significance of integrating computational modeling with experimental photophysics and bioassays. Theoretical insights into electronic transitions and vibrational behaviors guided the synthesis and selection of promising candidates like Hcy-ON. Such a synergy between theory and experiment is indispensable for accelerating the discovery and development of advanced functional materials in biomedicine.

Importantly, the collaborative international effort underscores the value of interdisciplinary and cross-institutional research in tackling complex challenges like cancer therapy. By combining expertise in synthetic chemistry, photophysics, molecular modeling, and biomedical engineering, the team delivered a comprehensive study with practical translational potential. Their work sets a precedent for future explorations of AIE-based NIR dyes in multimodal therapeutic and diagnostic applications.

In conclusion, the development of this dye series with fine-tuned AIE properties and enhanced NIR excitation represents a transformative stride in photomedicine. Their capability to simultaneously excel in photodynamic and photothermal modalities, coupled with efficient photoacoustic imaging, paves the way for versatile and effective cancer treatments. Continued research building on this electron-acceptor engineering blueprint is poised to unlock new horizons in non-invasive, light-driven tumor therapies, reshaping the landscape of personalized medicine.

As the scientific community strives toward safer, more efficient cancer interventions, innovations like those from Academician Xiaojun Peng’s and Professor Juyoung Yoon’s teams provide a beacon of hope. Their work opens avenues not only for superior therapeutic agents but also for better diagnostic tools that collectively enhance patient outcomes. This promising research invites further exploration and clinical translation to bring these molecular achievements from the laboratory bench to bedside reality.

Subject of Research: Development of near-infrared aggregation-induced emission dyes for multimodal cancer therapies

Article Title: (Not specified in the provided content)

News Publication Date: (Not specified in the provided content)

Web References: (Not specified in the provided content)

References: Published in CCS Chemistry

Image Credits: EurekAlert! / Dalian University of Technology

Keywords

Near-infrared dyes, Aggregation-induced emission, Photodynamic therapy, Photothermal therapy, Photoacoustic imaging, Electron-acceptor engineering, Xanthene derivatives, Reactive oxygen species, Spin–orbit coupling, Molecular photophysics, Multimodal cancer therapy, Molecular excited-state dynamics